Dimopoulos, Meletios A. Dytfeld, Dominik Grosicki, Sebastian and Moreau, Philippe Takezako, Naoki Hori, Mitsuo Leleu, Xavier and LeBlanc, Richard Suzuki, Kenshi Raab, Marc S. and Richardson, Paul G. McKiver, Mihaela Popa Jou, Ying-Ming and Shelat, Suresh G. Robbins, Michael Rafferty, Brian and San-Miguel, Jesus, Elotuzumab, Pomalidomide, and Dexamethasone for Relapsed/Refractory
Multiple Myeloma: Efficacy After Additional Follow-Up of the ELOQUENT-3
Study, Clinical Lymphoma Myeloma & Leukemia, (19), E164-E165, 2019, CIG MEDIA GROUP, LP, 2152-2650, 2152-2669